Precision Medicine for AD

Precision medicine is a type of medical therapy and prevention that considers individual differences in genes, environment, and lifestyle, and allows for tailoring based on factors that may influence treatment response. Several genetic and epigenetic risk factors have been linked to late-onset Alzheimer's disease susceptibility (AD). As a result, including genetic risk variables into the AD prevention approach, which has previously mostly focused on universal risk-reduction methods for the whole population rather than personalized, targeted therapies, may be advantageous. This approach to medicine holds a lot of promise for treating the intricacies of people with diverse genetics, lifestyle circumstances, and medical comorbidities who may have different responses to treatment.

  • Precision Medicine
  • Biomarkers for Alzheimer's Disease
  • “One-Size-Fits-All” Approach to AD Prevention
  • Future Perspectives
Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jun Hua

Jun Hua

Johns Hopkins University , United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Nazneen N Dewji

Nazneen N Dewji

Cenna Biosciences Inc, United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline London

Jacqueline London

Paris Diderot University, France

Submit your abstract Today

Whatsapp